Do GLP-1 supplements work?

By the · Updated · How we research
Bottom Line

Supplements sold as GLP-1 products are not Ozempic, Wegovy, Rybelsus, Mounjaro, or Zepbound. Berberine has meta-analyses in type 2 diabetes showing lower fasting glucose and HbA1c. We did not read a trial of berberine against semaglutide or tirzepatide, so the 'natural GLP-1' label is marketing.

Educational reference, not medical advice. This page cites only studies we read. It does not replace a clinician, especially if you are pregnant, have kidney disease, or already take a prescription.

Search results and supplement labels now say GLP-1 the way they used to say keto. Ozempic, Wegovy, and Rybelsus are semaglutide. Mounjaro and Zepbound are tirzepatide. Those are prescriptions. Berberine, gymnema, and bitter melon are not those drugs, and a bottle that borrows the name has not borrowed the trials.

What berberine has actually been tested for

The trials are about blood glucose in type 2 diabetes, not about matching a weekly injection.

Xie 2022 (PMID 36467075, doi:10.3389/fphar.2022.1015045) pooled 37 studies and 3,048 people with type 2 diabetes. Berberine lowered fasting glucose by 0.82 mmol/L (95% CI −0.95 to −0.70), HbA1c by 0.63 percentage points (−0.72 to −0.53), and 2-hour glucose by 1.16 mmol/L (−1.36 to −0.96). The size of the glucose effect depended on how high fasting glucose and HbA1c were at the start. The abstract says berberine alone or with other diabetes tablets did not significantly increase total adverse events, and prints a relative risk of 0.73 (0.55 to 0.97, p = 0.03), which is a decrease, not a null result. Hypoglycemia was not clearly different (relative risk 0.48, 0.21 to 1.08, p = 0.08).

Liang 2019 (PMID 30393248) pooled 28 studies and 2,313 people. Fasting glucose fell by 0.54 mmol/L (−0.77 to −0.30) and post-meal glucose by 0.94 mmol/L (−1.27 to −0.61). The abstract also prints an HbA1c weighted mean difference of −0.54 and labels the unit mmol/L. HbA1c is not usually written that way. Xie, above, reports HbA1c in percentage points. Do not treat −0.54 mmol/L and −0.63% as the same number. Liang's subgroup note matters: the glucose effect became unremarkable when treatment ran past 90 days, when the dose was over 2 g/day, or when patients were over 60. Berberine plus a diabetes drug beat either one alone in that review.

The head-to-head with metformin is a 2008 pilot, not a modern outcome trial. It is summarized on berberine vs metformin. The metformin group's glucose numbers are not in the abstract. The authors said the effect looked similar. Twenty people (34.5%) had transient stomach side effects.

What that does not show

None of these papers compared berberine with semaglutide or tirzepatide. None of them is a weight-loss trial of a "GLP-1 supplement" against Ozempic, Wegovy, Mounjaro, or Zepbound. A lower HbA1c in type 2 diabetes is a real finding and a different claim from "this is the natural version of the injection."

Gymnema and bitter melon are in the older mimicking-supplements article. This page does not add new numbers for them, because those trials were not the ones re-read for this update. The skeptical berberine essay is Is berberine nature's Ozempic?

Questions people ask

Do GLP-1 supplements work like Ozempic, Wegovy, or Zepbound?

No trial we read compared berberine, or any other supplement, with semaglutide or tirzepatide. Berberine has lowered glucose markers in type 2 diabetes meta-analyses. That is not the same result as the prescription drugs.

Is berberine nature's Ozempic?

It is a plant alkaloid with glucose data in type 2 diabetes, including one small pilot that the authors said looked similar to metformin. It is not semaglutide, and the metformin comparison did not print the metformin group's numbers in the abstract.

Sources

  1. Xie W, et al. "Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis." Front Pharmacol. 2022;13:1015045. PMID 36467075. DOI 10.3389/fphar.2022.1015045. PROSPERO CRD42021292975.
  2. Yin J, Xing H, Ye J. "Efficacy of berberine in patients with type 2 diabetes mellitus." Metabolism. 2008;57(5):712-717. PMID 18442638. DOI 10.1016/j.metabol.2008.01.013.
  3. Liang Y, et al. "Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis." Endocr J. 2019;66(1):51-63. PMID 30393248. DOI 10.1507/endocrj.EJ18-0109.

Reviewed against 3 peer-reviewed sources.

Supplements mentioned